Cigna Group (NYSE:CI – Get Free Report) declared a quarterly dividend on Wednesday, July 22nd. Investors of record on Tuesday, September 8th will be given a dividend of 1.56 per share by the health services provider on Wednesday, September 23rd. This represents a c) dividend on an annualized basis and a yield of 2.2%. The ex-dividend date is Tuesday, September 8th.
Cigna Group has increased its dividend by an average of 1.7%per year over the last three years and has increased its dividend annually for the last 5 consecutive years. Cigna Group has a payout ratio of 18.9% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Cigna Group to earn $33.41 per share next year, which means the company should continue to be able to cover its $6.24 annual dividend with an expected future payout ratio of 18.7%.
Cigna Group Trading Down 1.8%
Shares of NYSE CI opened at $285.29 on Thursday. The business has a fifty day simple moving average of $286.11 and a 200-day simple moving average of $280.66. The company has a market cap of $75.47 billion, a price-to-earnings ratio of 12.09, a P/E/G ratio of 1.12 and a beta of 0.29. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47.
Insider Transactions at Cigna Group
In other news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This trade represents a 85.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the business. Wilkerson Advisory Group LLC purchased a new position in Cigna Group during the 4th quarter valued at about $25,000. Beacon Financial Strategies CORP purchased a new stake in shares of Cigna Group in the fourth quarter valued at approximately $28,000. Cedar Mountain Advisors LLC grew its stake in Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares during the last quarter. Kemnay Advisory Services Inc. purchased a new stake in Cigna Group during the 4th quarter worth approximately $29,000. Finally, Prosperity Bancshares Inc acquired a new position in Cigna Group during the fourth quarter valued at $29,000. 86.99% of the stock is owned by hedge funds and other institutional investors.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Read More
- Five stocks we like better than Cigna Group
- Rocket Lab Has Corrected Nearly 50%. Is It Still Too Expensive?
- Cybersecurity ETFs Are Rallying While AI Stocks Cool Off
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
